IMMUPHARMA SA (IPP-201101/006)

By June 19, 2019 Closed

An open-label study of the safety and tolerability of repeated administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Leave a Reply